 |
市場調查報告書
商品編碼
1741509
神經影像市場：按技術、應用、最終用戶和地區分類Neuroimaging Market, By Technology, By Application, By End User, By Geography |
||||||
價格
簡介目錄
神經影像市場規模預計在 2025 年達到 422.8 億美元，預計到 2032 年將達到 635.7 億美元，2025 年至 2032 年的年複合成長率為 6%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 422.8億美元 |
| 效能數據 | 從2020年到2024年 | 預測期 | 2025年至2032年 |
| 預測期：2025-2032年年複合成長率： | 6.00% | 2032年價值預測 | 635.7億美元 |
神經影像學是醫療圖像的一個分支，它能夠將大腦結構和功能視覺化。它為理解各種疾病和病症背後的神經過程和異常提供了寶貴的見解。這項技術徹底改變了神經科學領域，並大大促進了我們對人腦的理解。
市場動態：
神經影像市場受多種因素驅動。神經系統疾病的發生率不斷上升，對精準診斷工具的需求也隨之增加，進而推動了成像技術的普及。此外，磁振造影(MRI)、正子斷層掃描 (PET) 和電腦斷層掃描 (CT) 等影像技術的進步，顯著提高了腦部影像的解析度和準確性。
然而，市場中也存在一些限制因素。神經影像設備的高昂成本以及相關的維護和運作成本限制了其普及，尤其是在開發中地區。某些顯像模式的安全問題，例如電腦斷層掃描中暴露於電離輻射，也對市場成長構成了挑戰。
然而，神經影像市場蘊含著許多商機。預計將加大對研發 (R&D) 活動的投資，以開發功能性磁振造影(fMRI) 和擴散張量造影 (DTI) 等先進影像技術，將推動市場成長。個人化醫療的日益普及以及人工智慧 (AI) 在神經影像領域的整合，為市場擴張提供了新的途徑。
本研究的主要特點
- 本報告對神經影像市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和年複合成長率(CAGR)。
- 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
- 神經影像市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 神經影像市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員將透過用於分析神經影像市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 市場限制
- 市場機會
- 主要亮點
- 監管情景
- 近期動態
- 產品發布/核准
- PEST分析
- 波特分析
- 合併、收購和合作
第4章 神經影像市場－冠狀病毒 (COVID-19) 大流行的影響
- COVID-19流行病學
- 供需側分析
- 經濟影響
5. 神經影像市場（依技術分類），2020 年至 2032 年
- 磁振造影（MRI）
- 電腦斷層掃描（CT）
- 正子斷層掃描（PET）
- 單光子發射電腦斷層掃描（SPECT）
- 功能性磁振造影（fMRI）
- 擴散張量成像（DTI）
- 腦磁圖（MEG）
- 腦電圖（EEG）
- 其他
6. 神經影像市場（依應用分類），2020 年至 2032 年
- 神經系統疾病
- 阿茲海默症
- 帕金森氏症
- 多發性硬化症
- 癲癇
- 中風
- 其他
- 精神疾病
- 思覺失調症
- 躁鬱症
- 憂鬱症
- 焦慮症
- 其他
- 創傷性腦損傷（TBI）
- 腦腫瘤
- 其他
7. 神經影像市場（依最終使用者分類），2020 年至 2032 年
- 醫院和診所
- 診斷中心
- 研究機構
- 門診手術中心
- 其他
8. 2020 年至 2032 年神經影像市場（按地區）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第9章 競爭態勢
- 公司簡介
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- NeuroVive Pharmaceutical AG
- Brainlab AG
- Akili Interactive Labs Inc.
- Brainomix Ltd.
- Imaging Science International
- Mevis Medical Solutions
- NeuroVista
- Neusoft Medical Systems
- Positron Corporation
- Shimadzu Corporation
- Trifoil Imaging.
第 10 章 章節
- 參考
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI6384
Neuroimaging Market is estimated to be valued at USD 42.28 Bn in 2025 and is expected to reach USD 63.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 42.28 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.00% | 2032 Value Projection: | USD 63.57 Bn |
Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underline various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.
Market Dynamics:
The neuroimaging market is driven by several factors. Growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, thus leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.
However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.
Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development (R&D) activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.
Key features of the study:
- This report provides in-depth analysis of the neuroimaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, and Trifoil Imaging..
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the neuroimaging market
Detailed Segmentation:
- Neuroimaging Market, By Technology:
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Functional Magnetic Resonance Imaging (fMRI)
- Diffusion Tensor Imaging (DTI)
- Magnetoencephalography (MEG)
- Electroencephalography (EEG)
- Others
- Neuroimaging Market, By Application:
- Neurological Disorders
- Alzheimers Disease
- Parkinsons Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Brain Tumors
- Others
- Neuroimaging Market, By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research Institutes
- Ambulatory Surgical Centers
- Others
- Neuroimaging Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- NeuroVive Pharmaceutical AG
- Brainlab AG
- Akili Interactive Labs Inc.
- Brainomix Ltd.
- Imaging Science International
- Mevis Medical Solutions
- NeuroVista
- Neusoft Medical Systems
- Positron Corporation
- Shimadzu Corporation
- Trifoil Imaging
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Market Restraints
- Market Opportunities
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTERs Analysis
- Mergers, Acquisitions, and Collaborations
4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Neuroimaging Market, By Technology, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Functional Magnetic Resonance Imaging (fMRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diffusion Tensor Imaging (DTI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Magnetoencephalography (MEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Electroencephalography (EEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Neuroimaging Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Alzheimers Disease
- Parkinsons Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Brain Tumors
- Others
7. Neuroimaging Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Neuroimaging Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Company Profile
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Toshiba Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Esaote SpA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroLogica Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroVive Pharmaceutical AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Brainlab AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Akili Interactive Labs Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Brainomix Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Imaging Science International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mevis Medical Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroVista
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Neusoft Medical Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Positron Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shimadzu Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Trifoil Imaging.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- References
- Research Methodology
- About us
